Literature DB >> 8270980

The cancer anorexia-cachexia syndrome.

K A Nelson1, D Walsh, F A Sheehan.   

Abstract

PURPOSE: To review the research related to the anorexia-cachexia syndrome in patients with cancer, with attention to the etiology and symptomatic treatment.
DESIGN: A comprehensive literature review using MEDLINE. RESULTS AND
CONCLUSION: The anorexia-cachexia syndrome is a common problem in advanced cancer. Although many possible etiologies have been investigated, the cause has not been determined. Appropriate clinical evaluation is necessary to identify those patients who may respond to available, symptomatic treatments.

Entities:  

Mesh:

Year:  1994        PMID: 8270980     DOI: 10.1200/JCO.1994.12.1.213

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  28 in total

Review 1.  Managing cancer-related anorexia/cachexia.

Authors:  G Mantovani; A Macciò; E Massa; C Madeddu
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Anorexia-Cachexia syndrome in cancer: implications of the ubiquitin-proteasome pathway.

Authors:  Carlos Camps; Vega Iranzo; Roy M Bremnes; Rafael Sirera
Journal:  Support Care Cancer       Date:  2006-07-04       Impact factor: 3.603

3.  Suffering and dying in cancer patients. Research frontiers in controlling confusion, cachexia, and dyspnea.

Authors:  N MacDonald
Journal:  West J Med       Date:  1995-09

4.  Residual Ca2+ channel current modulation by megestrol acetate via a G-protein alpha s-subunit in rat hypothalamic neurones.

Authors:  A M Costa; K T Spence; C R Plata-Salamán; J M ffrench-Mullen
Journal:  J Physiol       Date:  1995-09-01       Impact factor: 5.182

5.  Measuring body composition using the bioelectrical impedance method can predict the outcomes of gemcitabine-based chemotherapy in patients with pancreatobiliary tract cancer.

Authors:  Mami Muramatsu; Aya Tsuchiya; Seiko Ohta; Yukie Iijima; Miyuki Maruyama; Yoshiko Onodera; Megumi Hagihara; Naoki Nakaya; Itaru Sato; Kenji Omura; Soichiro Ueno; Hideo Nakajima
Journal:  Oncol Lett       Date:  2015-10-16       Impact factor: 2.967

6.  Gastrointestinal symptoms, electrogastrography, inflammatory markers, and PG-SGA in patients with advanced cancer.

Authors:  Martin Chasen; Ravi Bhargava
Journal:  Support Care Cancer       Date:  2011-06-19       Impact factor: 3.603

7.  Serum levels of tumour necrosis factor alpha and other cytokines do not correlate with weight loss and anorexia in cancer patients.

Authors:  M Maltoni; L Fabbri; O Nanni; E Scarpi; L Pezzi; E Flamini; A Riccobon; S Derni; G Pallotti; D Amadori
Journal:  Support Care Cancer       Date:  1997-03       Impact factor: 3.603

8.  The effect of cyproheptadine hydrochloride (periactin) and megestrol acetate (megace) on weight in children with cancer/treatment-related cachexia.

Authors:  Marisa Couluris; Jennifer L R Mayer; David R Freyer; Eric Sandler; Ping Xu; Jeffrey P Krischer
Journal:  J Pediatr Hematol Oncol       Date:  2008-11       Impact factor: 1.289

Review 9.  Anorexia in older persons: epidemiology and optimal treatment.

Authors:  J E Morley
Journal:  Drugs Aging       Date:  1996-02       Impact factor: 3.923

10.  Components of the anorexia-cachexia syndrome: gastrointestinal symptom correlates of cancer anorexia.

Authors:  Tugba Yavuzsen; Declan Walsh; Mellar P Davis; Jordanka Kirkova; Tao Jin; Susan LeGrand; Ruth Lagman; Lesley Bicanovsky; Bassam Estfan; Bushra Cheema; Abdo Haddad
Journal:  Support Care Cancer       Date:  2009-04-07       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.